Mig-6 suppresses endometrial cancer associated with Pten deficiency and ERK activation.
about
Mitogen-Inducible Gene-6 Mediates Feedback Inhibition from Mutated BRAF towards the Epidermal Growth Factor Receptor and Thereby Limits Malignant TransformationARID1A Is Essential for Endometrial Function during Early PregnancyLKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitmentProtein Inhibitor of Activated STAT3 (PIAS3) Is Down-Regulated in Eutopic Endometrium of Women with Endometriosis.KRAS Activation and over-expression of SIRT1/BCL6 Contributes to the Pathogenesis of Endometriosis and Progesterone Resistance.G-protein coupled receptor 64 is required for decidualization of endometrial stromal cells.Rational Optimization of Tumor Suppressor-Derived Peptide Inhibitor Selectivity between Oncogene Tyrosine Kinases ErbB1 and ErbB2.The expression of ER, PR in endometrial cancer and analysis of their correlation with ERK signaling pathway.Conditional abrogation of transforming growth factor-β receptor 1 in PTEN-inactivated endometrium promotes endometrial cancer progression in mice.Conversion of MIG6 peptide from the nonbinder to binder of lung cancer-related EGFR by phosphorylation and cyclization.Mig-6 Mouse Model of Endometrial Cancer.Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses.MIG-6 suppresses endometrial epithelial cell proliferation by inhibiting phospho-AKT.Modeling Endometrial Cancer: Past, Present, and Future
P2860
Q28548302-592688D8-C333-4625-824A-4139409ABFEBQ30370823-AC20CA7D-2E8F-4DE1-AB48-DA82EF6FD668Q36266500-B863F558-8CA2-42A0-BBBF-CC37B76D4F6FQ37268557-2335A87E-4417-420A-9174-6EF3C86AD2D8Q38654299-E3956270-705F-4BF3-8224-09691D4D4642Q40973699-30A914F6-6547-4E8F-9BA8-C9F4374C36AFQ47409545-9CC8CF22-7168-43B3-A762-9F7EA5C6181BQ47590366-E00C95AC-BB1D-4CEB-9C27-E0A7B0D9D9A2Q48210146-3AAA5851-314D-436C-8456-4F385AE941B1Q50792383-AFC784AC-1B7D-4072-A9C4-47D84F47D42BQ51290637-47B46EC8-D761-46EC-B564-725FEDF24A5CQ54940815-ACC46530-9114-4B06-932A-5BDF2B375233Q54968730-140004E1-52B1-4F1C-9EB0-17FEE0648F5EQ57170070-FADA0629-FEE1-45B8-B6FA-481219D77143
P2860
Mig-6 suppresses endometrial cancer associated with Pten deficiency and ERK activation.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Mig-6 suppresses endometrial cancer associated with Pten deficiency and ERK activation.
@ast
Mig-6 suppresses endometrial cancer associated with Pten deficiency and ERK activation.
@en
Mig-6 suppresses endometrial cancer associated with Pten deficiency and ERK activation.
@nl
type
label
Mig-6 suppresses endometrial cancer associated with Pten deficiency and ERK activation.
@ast
Mig-6 suppresses endometrial cancer associated with Pten deficiency and ERK activation.
@en
Mig-6 suppresses endometrial cancer associated with Pten deficiency and ERK activation.
@nl
prefLabel
Mig-6 suppresses endometrial cancer associated with Pten deficiency and ERK activation.
@ast
Mig-6 suppresses endometrial cancer associated with Pten deficiency and ERK activation.
@en
Mig-6 suppresses endometrial cancer associated with Pten deficiency and ERK activation.
@nl
P2093
P2860
P1433
P1476
Mig-6 suppresses endometrial cancer associated with Pten deficiency and ERK activation.
@en
P2093
Bon Jeong Ku
Gordon B Mills
Hong Im Kim
Jae-Wook Jeong
Jenifer Gilbert
Jeong Mook Lim
John P Lydon
Russell R Broaddus
Tae Hoon Kim
P2860
P304
P356
10.1158/0008-5472.CAN-14-0794
P407
P577
2014-11-06T00:00:00Z